polypharmacy

Gunathilaka, N. J., Gooden, T. E., Cooper, J., Flanagan, S., Marshall, T., Haroon, S., et al. (2024). Perceptions on artificial intelligence-based decision-making for coexisting multiple long-term health conditions: protocol for a qualitative study with patients and healthcare professionals. Bmj Open, 14, e077156. http://doi.org/10.1136/bmjopen-2023-077156
Joseph, R. M., Knaggs, R. D., Coupland, C. A. C., Taylor, A., Vinogradova, Y., Butler, D., et al. (2023). Frequency and impact of medication reviews for people aged 65 years or above in UK primary care: an observational study using electronic health records. Bmc Geriatr, 23, 435. http://doi.org/10.1186/s12877-023-04143-2
Jeffery, A., Bhanu, C., Walters, K., Wong, I. C., Osborn, D., & Hayes, J. F. (2023). Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data. Br J Gen Pract, 73, e392-e398. http://doi.org/10.3399/bjgp.2022.0295
Subramanian, A., Azcoaga-Lorenzo, A., Anand, A., Phillips, K., Lee, S. I., Cockburn, N., et al. (2023). Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. Bmc Med, 21, 21. http://doi.org/10.1186/s12916-022-02722-5
Elhussein, L., Jödicke, A. M., He, Y., Delmestri, A., Robinson, D. E., . Y. Strauss, V., & Prieto-Alhambra, D. (2023). Characterising complex health needs and the use of preventive therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data. Bmc Geriatr, 23, 58. http://doi.org/10.1186/s12877-023-03770-z
Jeffery, A., Bhanu, C., Walters, K., Wong, I. C. K., Osborn, D., & Hayes, J. F. (2022). Association between polypharmacy and depression relapse in individuals with comorbid depression and type 2 diabetes: a UK electronic health record study. Br J Psychiatry, 1-7. http://doi.org/10.1192/bjp.2022.160